Tissue- and time-dependent estrogen receptor activation in estrogen reporter mice

Journal of Molecular Endocrinology

Volumn 32, Issue 3, 2004, Pages 689-701

  Lemmen, J G ^a,c   Arends, R J ^b   van Boxtel, A L ^a   van der Saag, Paul T ^a   van der Burg, B ^a,d  

^a HUBRECHT INSTITUTE   (Netherlands)

^b NV Organon ^*  (Netherlands)

^c Mental Health Services CPH   (Denmark)

^d BIODETECTION SYSTEMS B V   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; DIETHYLSTILBESTROL; ESTRADIOL DIPROPIONATE; ESTROGEN RECEPTOR; FULVESTRANT; LUCIFERASE; RECEPTOR BLOCKING AGENT; TATA BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE; BRAIN; COLON; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; EX VIVO STUDY; FEMALE; GENE ACTIVATION; HYPOPHYSIS; IMAGING SYSTEM; IN VIVO STUDY; KIDNEY; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROTEIN LOCALIZATION; TATA BOX; TESTIS; TIME; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

ANIMALS; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGENS, NON-STEROIDAL; FEMALE; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; LUCIFERASES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; RECEPTORS, ESTROGEN; RESPONSE ELEMENTS; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 3042712865     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0320689     Document Type: Article

References (31)

1. Andersen HR, Andersson AM, Arnold SF, Autrup H, Barfoed M, Beresford NA, Bjerregaard P, Christiansen LB, Gissel B, Hummel R et al. 1999 Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals. Enviromental Health Perspectives 107 Suppl 1 89-108.
2. Ashby J, Odum J, Paton D, Lefevre PA, Beresford N & Sumpter JP 2000 Re-evaluation of the first synthetic estrogen, 1-keto-1,2,3,4-tetrahydrophenanthrene, and bisphenol A, using both the ovariectomised rat model used in 1933 and additional assays. Toxicology Letters 115 231-238.
3. Bengtsson G & Ullberg S 1963 The auroradiographic distribution pattern after administration of diethylstilboestrol compared with that of natural oestrogens. Acta Endocrinologica 43 561-570.
4. Carreau S 2001 Germ cells: a new source of estrogens in the male gonad. Molecular and Cellular Endocrinology 178 65-72.
5. Chung JH, Whiteley M & Felsenfeld G 1993 A 5′ element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila. Cell 74 505-514.
6. Ciana P, Di Luccio G, Belcredito S, Pollio G, Vegeto E, Tatangelo L, Tiveron C & Maggi A 2001 Engineering of a mouse for the in vivo profiling of estrogen receptor activity. Molecular Endocrinology 15 1104-1113.
7. Ciana P, Raviscioni M, Mussi P, Vegeto E, Que I, Parker MG, Lowik C & Maggi A 2003 In vivo imaging of transcriptionally active estrogen receptors. Nature Medicine 9 82-86.
8. Diel P, Schulz T, Smolnikar K, Strunck E, Vollmer G & Michna H 2000 Ability of xeno- and phytoestrogens to modulate expression of estrogen-sensitive genes in rat uterus: estrogenicity profiles and uterotropic activity. Journal of Steroid Biochemistry and Molecular Biology 73 1-10.
9. Di Lorenzo D, Villa R, Biasiotto G, Belloli S, Ruggeri G, Albertini A, Apostoli P, Raviscioni M, Ciana P & Maggi A 2002 Isomer-specific activity of dichlorodyphenyltrichloroethane with estrogen receptor in adult and suckling estrogen reporter mice. Endocrinology 143 4544-4351.
10. Farhat MY, Lavigne MC & Ramwell PW 1996 The vascular protective effects of estrogen. FASEB Journal 10 615-624.
11. Grese TA, Sluka JP, Bryant HU, Cullinan CJ, Glasebrook AL, Jones CD, Matsumoto K, Palkowitz AD, Sato M, Termine JD, Winter MA, Yang NN & Dodge JA 1997 Molecular determinants of tissue selectivity in estrogen receptor modulators. PNAS 94 14105-14110.
12. Harrington WR, Sheng S, Barnett DH, Petz LN, Katzenellenbogen JA & Katzenellenbogen BS 2003 Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Molecular and Cellular Endocrinology 206 13-22.
13. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TRJ, Lubahn DB, O'Donnell TFJ, Korach KS & Mendelsohn ME 1997 Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nature Medicine 3 345-548.
14. Jefferson WN, Padilla-Banks E, Clark G & Newbold RR 2002 Assessing estrogenic activity of phytochemicals using transcriptional activation and immature mouse uterotrophic responses. Journal of Chromatography B 777 179-189.
15. Khurana S, Ranmal S & Ben-Jonathan N 2000 Exposure of newborn male and female rats to environmental estrogens: delayed and sustained hyperprolactinemia and alterations in estrogen receptor expression. Endocrinology 141 4512-4317.
16. Korach KS, Migliaccio S & Davis VL 1994 Estrogens. In Principles of Pharmacology - Basic Concepts and Clinical Applications, pp 809-825. Ed PL Munson. New York: Chapman and Hall.
17. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S & Gustafsson JA 1997 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138 863-870.
18. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B & Gustafsson JA 1998 Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139 4252-4263.
19. LeBlanc GA, Bain LJ & Wilson VS 1997 Pesticides: multiple mechanisms of demasculinization. Molecular and Cellular Endocrinology 126 1-5.
20. Legler J, van den Brink CE, Brouwer A, Murk AJ, van der Saag PT, Vethaak AD & van der Burg B 1999 Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Toxicological Sciences 48 55-66.
21. Legler J, Broekhof JLM, Brouwer A, Lanser PH, Murk AJ, van der Saag PT, Wester P, Zivkovic D & van Der B 2000 A novel in vivo bioassay for (xeno-)estrogens using transgenic zebrafish. Environmental Science and Technology 34 4439-4444.
22. McLachlan JA 1977 Prenatal exposure to diethylstilbestrol in mice: toxicological studies. Journal of Toxicology and Environmental Health 2 527-537.
23. Nagel SC, Hagelbarger JL & McDonnell DP 2001 Development of an ER action indicator mouse for the study of estrogens, selective ER modulators (SERMs), and xenobiotics. Endocrinology 142 4721-4728.
24. Pennie WD, Aldridge TC & Brooks AN 1998 Differential activation by xenoestrogens of ER alpha and ER beta when linked to different response elements. Journal of Endocrinology 158 R11-R14.
25. Potts W, Tucker D, Wood H & Martin C 2000 Chicken beta-globin 5′HS4 insulators function to reduce variability in transgenic founder mice. Biochemical and Biophysical Research Communications 273 1015-1018.
26. Schlumpf M, Cotton B, Conscience M, Haller V, Steinmann B & Lichtensteiger W 2001 In vitro and in vivo estrogenicity of UV screens. Environmental Health Perspectives 109 239-244.
27. Setchell B & Main S 1978 Drugs and the blood testis barrier. Environmental Health Perpectives 24 61-64.
28. Shang Y & Brown M 2002 Molecular determinants for the tissue specificity of SERMs. Science 295 2465-2468.
29. Toda K, Okada Y, Zubair M, Morohashi KI, Saibara T & Okada T 2003 Aromatase-knockout mouse carrying an estrogen-inducible enhanced green fluorescent protein gene facilitates detection of estrogen actions in vivo. Endocrinology 145 1880-1888.
30. Turner RT, Riggs BL & Speslberg TC 1994 Skeletal effects of estrogen. Endocrine Reviews 15 275-300.
31. Wang Y, DeMayo FJ, Tsai SY & O'Malley BW 1997 Ligand-inducible and liver-specific target gene expression in transgenic mice. Nature Biotechnology 15 239-243.